Kwmg, LLC Abb Vie Inc. Transaction History

Kwmg, LLC

$986 Million
Q3 2024

A detailed history of Kwmg, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kwmg, LLC holds 1,244 shares of ABBV stock, worth $208,693. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,244

Previous 1,244 -0.0%

Holding current value

$208,693

Previous $213,000 15.02%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $198,816 - $226,532	1,244 New	1,244 $226,000
Q1 2023 Apr 06, 2023	BUY	$144.61 - $166.54 $14,027 - $16,154	97 Added 7.65%	1,365 $217,000
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $175,377 - $210,323	1,268 New	1,268 $0
Q2 2019 Jul 10, 2019	SELL	$65.7 - $83.98 $64,123 - $81,964	-976 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $5,939 - $6,990	-77 Reduced 7.31%	976 $79,000
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $6,772 - $8,352	-87 Reduced 7.63%	1,053 $97,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $9,691 - $10,773	-109 Reduced 8.73%	1,140 $108,000
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $1.77 Million - $2.09 Million	-19,686 Reduced 94.03%	1,249 $116,000
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $551,139 - $738,027	-5,990 Reduced 22.25%	20,935 $1.98 Million
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $36,182 - $39,676	404 Added 1.52%	26,925 $2.6 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $1.85 Million - $2.37 Million	26,521	26,521 $2.36 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kwmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kwmg, LLC with notifications on news.

Account